Cargando…
Driving Immune Responses in the Ovarian Tumor Microenvironment
Ovarian cancer is the leading cause of death among gynecological neoplasms, with an estimated 14,000 deaths in 2019. First-line treatment options center around a taxane and platinum-based chemotherapy regimen. However, many patients often have recurrence due to late stage diagnoses and acquired chem...
Autores principales: | Ning, Franklin, Cole, Christopher B., Annunziata, Christina M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7843421/ https://www.ncbi.nlm.nih.gov/pubmed/33520713 http://dx.doi.org/10.3389/fonc.2020.604084 |
Ejemplares similares
-
Tumor Immune Microenvironment Related Gene-Based Model to Predict Prognosis and Response to Compounds in Ovarian Cancer
por: Yang, Jiang, et al.
Publicado: (2021) -
Tn Antigen Expression Contributes to an Immune Suppressive Microenvironment and Drives Tumor Growth in Colorectal Cancer
por: Cornelissen, Lenneke A. M., et al.
Publicado: (2020) -
Protein Glycosylation and Tumor Microenvironment Alterations Driving Cancer Hallmarks
por: Peixoto, Andreia, et al.
Publicado: (2019) -
Microenvironment immune response induced by tumor ferroptosis—the application of nanomedicine
por: Yun, Tian, et al.
Publicado: (2022) -
The effect of neoadjuvant chemotherapy on the tumor immune microenvironment in gastrointestinal tumors
por: Wang, Yujie, et al.
Publicado: (2022)